Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ELEVATE High-Risk PCI Pivotal Study

NCT07001332 is registered in ClinicalTrials.gov with Magenta Medical Ltd. as lead sponsor.

NCT NCT07001332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07001332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ELEVATE High-Risk PCI Pivotal Study
Lead sponsor
Magenta Medical Ltd.
Phase
Not applicable
Overall status
Recruiting
Start date
July 25, 2025
Completion date
September 16, 2027
Enrollment
290 (estimated)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

high-risk percutaneous coronary intervention (high-risk pci)